Transcription of LEMTRADA (2.1) - Sanofi
{{id}} {{{paragraph}}}
Example: bankruptcy
LEMTRADA (2.1) - Sanofi
HIGHLIGHTS OF prescribing information DOSAGE AND ADMINISTRATION . These highlights do not include all the information needed to use LEMTRADA safely and Administer LEMTRADA by intravenous infusion over 4 hours for 2 treatment courses: effectively. See full prescribing information for LEMTRADA . First course: 12 mg/day on 5 consecutive days. ( ). Second course: 12 mg/day on 3 consecutive days 12 months after first treatment course. LEMTRADA (alemtuzumab) injection, for intravenous use ( ). Initial Approval: 2001 Premedicate with corticosteroids prior to LEMTRADA infusion for the first 3 days of each treatment course. ( ). Administer antiviral agents for herpetic prophylaxis starting on the first day of LEMTRADA . dosing and continuing for a minimum of two months after completion of LEMTRADA dosing WARNING: autoimmunity , INFUSION REACTIONS, AND MALIGNANCIES or until CD4+ lymphocyte count is more than 200 cells per microliter, whichever occurs later.
FULL PRESCRIBING INFORMATION WARNING: AUTOIMMUNITY, INFUSION REACTIONS, AND MALIGNANCIES • LEMTRADA causes serious, sometimes fatal, autoimmune conditions such as immune thrombocytopenia and anti-glomerular basement membrane disease.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: